IRIS - Res&Arch Institutional Research Information System - Research & Archive

DI FILIPPO, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.831
AS - Asia 3.845
EU - Europa 3.247
SA - Sud America 748
Continente sconosciuto - Info sul continente non disponibili 338
AF - Africa 107
OC - Oceania 6
Totale 13.122
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.663
SG - Singapore 1.752
IT - Italia 642
BR - Brasile 558
CN - Cina 557
HK - Hong Kong 489
IE - Irlanda 480
RU - Federazione Russa 477
VN - Vietnam 400
FR - Francia 273
DE - Germania 249
UA - Ucraina 242
SE - Svezia 241
FI - Finlandia 173
GB - Regno Unito 123
KR - Corea 118
BD - Bangladesh 112
IN - India 79
CA - Canada 66
RO - Romania 64
AR - Argentina 58
NL - Olanda 53
MX - Messico 47
TR - Turchia 47
ID - Indonesia 42
CZ - Repubblica Ceca 40
IQ - Iraq 40
JP - Giappone 38
PL - Polonia 38
EC - Ecuador 32
ZA - Sudafrica 32
CO - Colombia 30
PK - Pakistan 29
AT - Austria 25
BE - Belgio 25
SA - Arabia Saudita 24
VE - Venezuela 24
UZ - Uzbekistan 22
ES - Italia 18
PH - Filippine 17
JM - Giamaica 14
PY - Paraguay 14
MA - Marocco 13
TN - Tunisia 13
CH - Svizzera 12
CL - Cile 12
LT - Lituania 12
GR - Grecia 11
LB - Libano 11
HR - Croazia 9
NI - Nicaragua 8
AE - Emirati Arabi Uniti 7
KE - Kenya 7
KZ - Kazakistan 7
BG - Bulgaria 6
BO - Bolivia 6
CR - Costa Rica 6
EG - Egitto 6
ET - Etiopia 6
PE - Perù 6
SC - Seychelles 6
UY - Uruguay 6
DZ - Algeria 5
JO - Giordania 5
MY - Malesia 5
PA - Panama 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
CG - Congo 4
IL - Israele 4
KG - Kirghizistan 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
HN - Honduras 3
IR - Iran 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AU - Australia 2
BW - Botswana 2
DK - Danimarca 2
EU - Europa 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MD - Moldavia 2
ME - Montenegro 2
MM - Myanmar 2
NO - Norvegia 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AM - Armenia 1
Totale 12.752
Salva come PNG Salva come JPEG
Città #
Singapore 1.266
Chandler 512
Hong Kong 487
Dublin 479
San Jose 461
Ashburn 345
Perugia 276
Boardman 229
San Mateo 218
Santa Clara 216
Moscow 173
Beijing 153
Altamura 137
Jacksonville 129
Lauterbourg 128
Dong Ket 121
Seoul 118
Los Angeles 116
Munich 112
Medford 110
Princeton 110
Lawrence 104
Wilmington 93
Ho Chi Minh City 88
Andover 86
Ann Arbor 81
New York 79
The Dalles 68
Des Moines 61
Hanoi 55
Piscataway 54
Turku 54
Phoenix 48
São Paulo 45
Helsinki 43
Frankfurt am Main 40
Redmond 40
Bucharest 35
Tokyo 35
Falls Church 34
Orem 29
Brno 27
Brooklyn 26
Chicago 26
Dallas 26
Warsaw 26
Chennai 25
Denver 25
Saint Petersburg 24
Atlanta 23
Houston 23
Montreal 23
Boston 22
Amsterdam 21
Brussels 20
Norwalk 20
Nuremberg 20
Johannesburg 19
London 19
Buffalo 18
Redwood City 18
Council Bluffs 17
Woodbridge 17
Haiphong 16
Quito 16
Rio de Janeiro 16
Stockholm 16
Vienna 16
Rome 15
Columbus 14
San Francisco 14
Ankara 13
Hefei 13
Poplar 13
Tashkent 13
Manchester 12
Milan 12
Timisoara 12
Toronto 12
Izmir 11
Kingston 11
Mexico City 11
Riyadh 11
Biên Hòa 10
Da Nang 10
Dhaka 10
Florence 10
Guangzhou 10
Baghdad 9
Belo Horizonte 9
Brasília 9
Campinas 9
Caracas 9
Den Haag 9
Falkenstein 9
San Paolo di Civitate 9
Shenzhen 9
Bogotá 8
Cleveland 8
Managua 8
Totale 7.975
Salva come PNG Salva come JPEG
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 221
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 177
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 162
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 152
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 143
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 143
Hippocampal epileptogenesis in autoimmune encephalitis 133
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 133
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 130
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 129
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 128
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 127
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 127
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 126
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 125
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 125
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 123
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 121
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 121
Plasticity and repair in the post-ischemic brain 119
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 118
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 118
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 118
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 118
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 115
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 114
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 112
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 112
ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors? 111
Ischemic bilateral hippocampal dysfunction during transient global amnesia. 109
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 107
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 106
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 105
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 104
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. 103
Basi neurobiologiche dei deficit cognitivi nella malattia di Parkinson 103
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 102
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 102
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2 102
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 101
Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction 101
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 101
Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis 101
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 101
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 100
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 100
Mitochondria and the link between neuroinflammation and neurodegeneration. 98
Direct and indirect pathways of basal ganglia: a critical reappraisal. 98
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 98
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. 97
Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS 97
A young patient with type C multiple system atrophy and hereditary hemochromatosis. 96
A pathophysiological link between dystonia, striatal interneurons and neuropeptide Y 95
Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature 94
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 93
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 92
Synaptic dysfunction in multiple sclerosis: A red thread from inflammation to network disconnection 92
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 91
La disfunzione sessuale nei pazienti con sclerosi multipla: prevalenza e impatto dei trattamenti sintomatici 90
Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis 89
Does cerebrospinal fluid neurofilament light chain correlate with psychiatric symptoms severity in multiple sclerosis? 88
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: A multicentre retrospective study 87
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 87
Distinct levels of dopamine denervation differentially alter striatal synapticplasticity and NMDA receptor subunit composition. 85
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 85
Insights into the pathophysiology of psychiatric symptoms in central nervous system disorders: Implications for early and differential diagnosis 85
The endocannabinoid system in Parkinson's disease. 84
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 84
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 84
Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. 83
CSF synaptic biomarkers and cognitive impairment in multiple sclerosis 82
Short-term and long-term plasticity at corticostriatal synapses: Implications for learning and memory. 82
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 82
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors 82
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop) 81
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica 81
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 80
An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases 80
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain 80
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 80
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 79
Teaching NeuroImages: Acute tetraparesis: Mind the brain 79
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 79
Neurofilament light chain as a biomarker in neurological disorders 79
Finding a way to preserve mitochondria: New pathogenic pathways in experimental multiple sclerosis 79
The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI 79
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. 78
Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. 77
Ischemic stroke injury is mediated by aberrant Cdk5 77
Multiple sclerosis and cognition: synaptic failure and network dysfunction 77
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 76
Cytokines, synaptic plasticity and network dynamics: a matter of balance 76
Impact of post-contrast MRI in the definition of active multiple sclerosis 76
Sensitization, glutamate, and the link between migraine and fibromyalgia. 76
Intrathecal B cell activation and memory impairment in multiple sclerosis 74
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 74
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion 73
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective 72
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease. 72
Serum neurofilament light chain as a preclinical marker of neurodegeneration 72
Totale 10.055
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.958
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022865 0 0 34 46 48 31 13 287 21 82 158 145
2022/20231.733 118 370 23 152 124 188 6 58 622 4 51 17
2023/2024914 38 84 33 61 6 2 164 13 120 32 161 200
2024/20252.219 27 202 82 105 229 175 111 209 389 136 362 192
2025/20265.259 360 364 282 765 703 491 809 274 515 405 192 99
2026/2027470 133 195 142 0 0 0 0 0 0 0 0 0
Totale 13.122